Thinking of joining a study?

Register your interest

Become a volunteer?

Clinical trials

2615 results

Sort By:

Digital Tools to Engage and Activate Patients During Hospitalization

Study ID: NCT06973707
Start Date: 2028-07-01
End Date: 2030-01
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

520

Intervention / Treatment

Passive Digital Tools

Active Digital Tools

Sponsor

Brigham and Women's Hospital

Source: clinicaltrials.gov

Share:
Add to list

Ketamine HCl Prolonged Release Oral Tablets for CRPS

Study ID: NCT06419985
Start Date: 2026-07
End Date: 2028-07
Study Type

Interventional

Study Phase

Phase2

No. of Participants

65

Intervention / Treatment

80mg/day Ketamine HCl Prolonged Release

160mg/day Ketamine HCl Prolonged Release

Sponsor

University of Southern California

Source: clinicaltrials.gov

Share:
Add to list

Development and Application of a Parenting Anxiety Intervention Program for Young and Middle-Aged Female Breast Cancer Patients

Study ID: NCT07331740
Start Date: 2026-03-01
End Date: 2026-12-01
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

20

Intervention / Treatment

Parenting Concerns Support Program

Sponsor

Shanghai University of Traditional Chinese Medicine

Source: clinicaltrials.gov

Share:
Add to list

Immunotherapy With Baricitinib and Sirolimus, Alone and in Combination, for the Control of HIV-1 Replication After Antiretroviral Treatment Interruption

Study ID: NCT07081763
Start Date: 2026-05
End Date: 2030-11
Study Type

Interventional

Study Phase

Phase2

No. of Participants

191

Intervention / Treatment

Baricitinib 2 mg

Sirolimus 2 MG

Placebo of baricitinib 2 MG

Placebo of sirolimus 2 MG

Sponsor

ANRS, Emerging Infectious Diseases

Source: clinicaltrials.gov

Share:
Add to list

Anti-CD30 biAb-AATC in Patients With Relapsed/Refractory CD30 Positive Hematopoietic Malignancies

Study ID: NCT05544968
Start Date: 2026-03
End Date: 2028-07
Study Type

Interventional

Study Phase

Phase1

No. of Participants

42

Intervention / Treatment

anti-CD30 Bispecific Antibody-armed anti-CD3-Activated Autologous T-cells (CD30 biAb-AATC)

GM-CSF

Sponsor

Medical College of Wisconsin

Source: clinicaltrials.gov

Share:
Add to list

Olpasiran Trials of Cardiovascular Events and Lipoprotein(a) Reduction - Coronary Computed Tomography Angiography Trial

Study ID: NCT07293260
Start Date: 2026-03-21
End Date: 2028-06-02
Study Type

Interventional

Study Phase

Phase3

No. of Participants

406

Intervention / Treatment

Olpassed

Placebo

Sponsor

Amgen

Source: clinicaltrials.gov

Share:
Add to list

Hepatic Lipid Metabolism-Alcohol Use Disorder

Study ID: NCT07191561
Start Date: 2026-02-03
End Date: 2029-11-30
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

25

Intervention / Treatment

Liver biopsy

Sponsor

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Source: clinicaltrials.gov

Share:
Add to list

PREcision MEDicine In Achalasia (PREMEDIA) - Cohort

Study ID: NCT07293689
Start Date: 2026-04-01
End Date: 2030-03-01
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

200

Intervention / Treatment
Sponsor

Northwestern University

Source: clinicaltrials.gov

Share:
Add to list

Multi-Omics Integrative Analysis of Serum and Sputum to Uncover Key Determinants of Prognosis in Patients With ARDS

Study ID: NCT07380997
Start Date: 2026-03-01
End Date: 2029-12-31
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

411

Intervention / Treatment
Sponsor

Ruisin Hospital

Source: clinicaltrials.gov

Share:
Add to list

Multimodal Differences in Effort-based Decision-Making in Depression

Study ID: NCT06648460
Start Date: 2026-08-01
End Date: 2030-09-30
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

90

Intervention / Treatment

Effort-based Decision-Making Task

Sponsor

Georgia Institute of Technology

Source: clinicaltrials.gov

Share:
Add to list